Provided by Tiger Trade Technology Pte. Ltd.

Merck

101.09
+0.40000.40%
Post-market: 101.05-0.0400-0.04%19:59 EST
Volume:44.98M
Turnover:4.55B
Market Cap:250.91B
PE:13.38
High:102.20
Open:100.60
Low:100.11
Close:100.69
52wk High:105.84
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:3.09
T/O Rate:1.81%
Dividend:3.24
Dividend Rate:3.21%
EPS(TTM):7.56
EPS(LYR):6.76
ROE:39.49%
ROA:13.76%
PB:4.84
PE(LYR):14.95

Loading ...

Halozyme Therapeutics: Outcome of the Infringement Lawsuit Against Merck Will Not Impact Enhanze

THOMSON REUTERS
·
Dec 05

BRIEF-Merck Says EXZOLT CATTLE-CA1 To Be Available By Prescription In Q1 2026

Reuters
·
Dec 05

Merck Gets Conditional FDA Approval for Cattle Antiparasitic

Dow Jones
·
Dec 05

Merck - Exzolt Cattle-CA1 Available by Prescription in Q1 2026

THOMSON REUTERS
·
Dec 05

FDA Conditionally Approves Merck Animal Health's Exzolt™ Cattle-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia Hominivorax) Larvae (Myiasis)

THOMSON REUTERS
·
Dec 05

BRIEF-FDA Conditionally Approves Topical Drug For Cattle Against New World Screwworm, Fever Tick

Reuters
·
Dec 05

The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch. -- Barrons.com

Dow Jones
·
Dec 05

FDA Official's Sudden Retirement Casts Shadow Over Oncology Drug Policies

Deep News
·
Dec 04

Scotiabank Adjusts Price Target on Merck & Co to $120 From $105, Maintains Sector Outperform Rating

MT Newswires Live
·
Dec 04

Trevi Therapeutics Names David Hastings as Chief Financial Officer

Reuters
·
Dec 04

BUZZ-Formycon rises on deal to commercialize Keytruda biosimilar

Reuters
·
Dec 04

U.S. RESEARCH ROUNDUP-Fiserv, PayPal, UMH Properties

Reuters
·
Dec 04

AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

Benzinga_recent_news
·
Dec 04

Dow Up Nearly 150 Points On Gains For Shares Of UnitedHealth, McDonald'S

Dow Jones
·
Dec 03

Merck Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Dec 03

US vaccine committee's hepatitis B changes would be most consequential yet

Reuters
·
Dec 03

BRIEF-Merck & Co Files For Seven- Part Notes Offering Of Up To $7.5 Billion- SEC Filing

Reuters
·
Dec 02

Merck & Co Inc Files for Seven- Part Notes Offering of up to $7.5 Bln- SEC Filing

THOMSON REUTERS
·
Dec 02

Merck & Co Files for Floating Rate Notes Due 2029 of up to $500 Mln

THOMSON REUTERS
·
Dec 02

BRIEF-Antengene Announces IND Approval In China For Phase Ib/II Study Of ATG-022 In Combination With Keytruda

Reuters
·
Dec 02